GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

UltraGreen.ai ULG.SI · SGD

Health Care · SGX · 🇸🇬 Singapore

Compare

0.39

-7.23%

Close of 6 Nov 2026, in SGD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$137.9m

FY2022FY2025

Net income

$75.6m

FY2022FY2025

Free cash flow

$45.1m

FY2022FY2025

Shareholders' equity

$310.6m

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
Revenue$137.9m$108.0m$72.0m$49.2m
Gross profit$117.1m$90.7m$56.8m$37.2m
Research and development———$173,400
Operating income$83.4m$66.3m$38.5m$23.8m
Net income$75.6m$56.0m$33.0m$23.5m
Diluted earnings per share0.070.050.030.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assets$335.6m$127.4m$130.4m$91.3m
Total liabilities$25.0m$25.0m$47.1m$35.8m
Debt—$2.0m——
Shareholders' equity$310.6m$102.4m$83.3m$55.5m
Shares outstanding1,103m1,103m1,103m1,103m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operations$53.3m$53.9m$25.5m$23.7m
Capital spending−$8.2m−$12.5m−$17.0m−$597,515
Free cash flow$45.1m$41.4m$8.5m$23.1m
Dividends paid−$39.8m−$55.8m−$11.5m−$6.4m

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Jun 2024
Revenue$137.9m$70.1m$108.0m$58.3m
Gross profit$117.1m$59.6m$90.7m$48.9m
Operating income$83.4m$42.7m$66.4m$35.1m
Net income$75.6m$25.7m$56.0m$27.8m
Diluted earnings per share0.060.020.050.03
Cash from operations$25.0m$27.0m$33.0m$20.0m
Capital spending−$5.0m−$2.0m−$10.0m−$1.0m
Free cash flow$20.0m$25.0m$23.0m$19.0m
Total assets$335.6m$162.2m$143.3m—
Debt—$1.9m$142.8m—
Shareholders' equity$310.6m$141.7m−$26.0m—

Financial ratios

Data as of 31 Oct 2026

FY2025FY2024FY2023FY2022
Gross margin84.9%83.9%78.8%75.5%
Operating margin52.7%61.9%52.8%51.0%
Net margin54.8%51.8%45.9%47.8%
Return on equity24.3%54.6%39.6%42.4%
Return on assets22.5%43.9%25.3%25.8%
Revenue growth27.7%50.0%46.4%—
Earnings growth35.2%69.4%40.3%—
Current ratio13.22x2.74x1.45x1.57x
Debt to equity0.00x0.02x0.00x0.00x
Equity ratio92.6%80.4%63.9%60.8%
Interest coverage562.02x1010.86x254.35x13641.26x
R&D as a share of sales———0.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue41.0%——
Operating income51.9%——
Net income47.6%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin84.5%82.2%——

Valuation history

At each fiscal year end

FY2025
Price to earnings13.9
Price to sales7.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.